Feature

Dissemination and implementation science underutilized in ID

November 12, 2019
Dissemination and implementation science is underutilized in the field of infectious diseases despite its demonstrated positive impact on clinical…
FDA News

European Union conditionally approves Merck’s Ebola vaccine, Ervebo

November 11, 2019
The European Commission granted conditional approval for Ervebo, Merck’s investigational Ebola virus vaccine, which has been used widely and…
Meeting News

Entasis enrolls first patient in phase 3 trial of gonorrhea treatment

November 11, 2019
WASHINGTON — Entasis Therapeutics announced at the World Anti-Microbial Resistance Congress that it has enrolled the first patient in a global…
Meeting News

Study identifies markers for pneumonia complications

November 11, 2019
Researchers have found three microRNAs that may predict respiratory failure and sepsis among patients with community-acquired pneumonia. …
In the Journals

Bacterial infection during pregnancy associated with psychosis in offspring

November 11, 2019
Maternal bacterial infection during pregnancy is associated with a significantly higher risk for psychotic disorders in offspring depending on…
Meeting News

New HCV infection less common in MSM initiating PrEP

November 11, 2019
BOSTON — New incidences of hepatitis C virus infection among men who have sex with men, or MSM, who are actively using pre-exposure prophylaxis…
FeaturePerspective

Stress-related diagnosis may increase risk for severe infections

November 11, 2019
Findings from a study conducted among more than 144,000 people in Sweden indicated that post-traumatic stress disorder, or PTSD, and other…
Meeting News

Herpes zoster vaccine uptake ‘low’ among older Nucala recipients

November 10, 2019
HOUSTON — Few patients with severe asthma treated with Nucala received herpes zoster and influenza vaccines in the years that followed, despite…
Meeting News

Say yes — and no — to eliminate physician burnout

November 10, 2019
HOUSTON — The ability to say yes and no can make a significant difference in the ability to prevent or eliminate physician burnout, according…
Meeting News

C. auris: ‘A ticking time bomb’ in need of new treatment options

November 9, 2019
WASHINGTON — Candida auris is a “ticking time bomb” — an aggressive and naturally resistant pathogen with few options for…
Meeting NewsVideo

VIDEO: Why aren't hospitals using new antibiotics?

November 8, 2019
WASHINGTON — In this video from the World Anti-Microbial Resistance Congress, Debra A. Goff, PharmD, FIDSA, an infectious diseases specialist…
Meeting News

Creatine equations comparable to measured GFR for HIV-positive patients

November 8, 2019
WASHINGTON — Ritonavir-boosted protease inhibitors do not significantly impact creatinine-based GFR estimates compared with measured GFR for…

Q&A: High-intensity vs. low-intensity prospective audit and feedback

November 8, 2019
Prospective audit and feedback is a staple intervention used by antimicrobial stewardship programs, or ASPs, to reduce antimicrobial use and improve…
Meeting NewsVideo

VIDEO: The pharmacist's role in antimicrobial stewardship

November 7, 2019
In this video from the World Anti-Microbial Resistance Congress, Kerry LaPlante, PharmD, FCCP, FIDSA, a professor of pharmacy at the University of…

US government sues Gilead over patent for HIV PrEP

November 7, 2019
The United States government filed a patent infringement lawsuit against Gilead Sciences in federal district court, accusing the drug maker of…
In the Journals

Prophylactic antibiotics decrease ventilator-associated pneumonia risk after cardiac arrest

November 7, 2019
A 2-day course of prophylactic antibiotic therapy lowered the incidence of early ventilator-associated pneumonia among patients treated with target…

Pricing agreement makes Priftin TB treatment affordable

November 7, 2019
A new agreement announced last week by Unitaid, the Global Fund and Sanofi drastically lowers the price of Priftin, a drug used for preventing…
In the JournalsPerspective

Takeda’s tetravalent dengue vaccine candidate effective in children

November 6, 2019
Results of an ongoing phase 3 trial of Takeda’s tetravalent dengue vaccine candidate, known as TAK-003, suggest that the vaccine is effective…
In the JournalsPerspective

Mailed HPV tests increase cervical cancer screening

November 6, 2019
Mailing HPV testing kits to women who were overdue for recommended Pap testing led to 50% more cervical cancer screenings but they did not increase…
FDA NewsPerspective

FDA approves Fluzone for older adults

November 6, 2019
The FDA approved a supplemental Biologic License Application for the Fluzone High-Dose Quadrivalent vaccine for the prevention of influenza in adults…